1. Home
  2. MX vs RANI Comparison

MX vs RANI Comparison

Compare MX & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnachip Semiconductor Corporation

MX

Magnachip Semiconductor Corporation

HOLD

Current Price

$3.09

Market Cap

107.6M

Sector

Technology

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.24

Market Cap

120.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MX
RANI
Founded
2003
2012
Country
South Korea
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.6M
120.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MX
RANI
Price
$3.09
$1.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$5.75
$8.67
AVG Volume (30 Days)
309.8K
1.2M
Earning Date
03-11-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$224,755,000.00
$1,200,000.00
Revenue This Year
N/A
$414.59
Revenue Next Year
N/A
$30.15
P/E Ratio
N/A
N/A
Revenue Growth
14.62
N/A
52 Week Low
$2.18
$0.39
52 Week High
$5.16
$3.87

Technical Indicators

Market Signals
Indicator
MX
RANI
Relative Strength Index (RSI) 49.93 29.86
Support Level $2.78 $1.07
Resistance Level $2.98 $1.26
Average True Range (ATR) 0.13 0.06
MACD -0.03 -0.02
Stochastic Oscillator 19.79 13.70

Price Performance

Historical Comparison
MX
RANI

About MX Magnachip Semiconductor Corporation

MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: